DataMEDS AI Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Revenue	7.68	23.34	18.13	-	-
Revenue Growth	-77.47%	28.73%	-	-	-
Cost of Revenue	14.75	29.76	16.36	-	-
Gross Profit	-7.07	-6.43	1.77	-	-
Selling, General & Admin	20.59	71.56	6.8	2.88	0.02
Operating Expenses	22.46	74.77	7.91	2.88	0.02
Operating Income	-29.53	-81.19	-6.15	-2.88	-0.02
Interest Expense	-6.76	-4.58	-0.83	-0.02	-
Other Non Operating Income (Expenses)	1.32	0.04	0.12	-	-
EBT Excluding Unusual Items	-34.97	-85.73	-6.86	-2.9	-0.02
Impairment of Goodwill	-2.03	-2.03	-	-	-
Asset Writedown	-10.53	-10.53	-	-	-
Other Unusual Items	4.12	-2.99	-	-	-
Pretax Income	-43.42	-101.27	-6.86	-2.9	-0.02
Net Income	-43.37	-101.27	-6.86	-2.9	-0.02
Net Income to Common	-43.37	-101.27	-6.86	-2.9	-0.02
Net Income Growth	-	-	-	-	-
Shares Outstanding (Basic)	2	1	1	1	-
Shares Outstanding (Diluted)	2	1	1	1	-
Shares Change	108.35%	50.23%	5.66%	-	-
EPS (Basic)	-17.63	-71.33	-7.25	-3.24	-
EPS (Diluted)	-17.63	-71.33	-7.25	-3.24	-
EPS Growth	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Gross Margin	-92.09%	-27.54%	9.75%	-	-
Operating Margin	-384.58%	-347.91%	-33.90%	-	-
Profit Margin	-564.77%	-433.95%	-37.82%	-	-
EBITDA	-27.66	-77.98	-5.03	-	-
EBITDA Margin	-	-	-27.75%	-	-
D&A For EBITDA	1.87	3.21	1.11	-	-
EBIT	-29.53	-81.19	-6.15	-2.88	-0.02
EBIT Margin	-	-	-33.90%	-	-